Valuation : MRI Interventions Inc

Market Cap 437M 377M 355M 323M 604M 41.24B 609M 4.2B 1.63B 21.08B 1.64B 1.6B 69.25B P/E 2026 *
-11x
P/E 2027 * -12x
Enterprise Value 437M 377M 355M 323M 604M 41.24B 609M 4.2B 1.63B 21.08B 1.64B 1.6B 69.25B EV / Sales 2026 *
8.91x
EV / Sales 2027 * 7.72x
Free-Float
94.56%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 49 07/11/2017
Director of Finance/CFO 41 01/01/2021
Chief Tech/Sci/R&D Officer - 01/01/2026
Director TitleAgeSince
Director/Board Member 68 10/03/2014
Chairman 80 04/02/2021
Director/Board Member 49 07/11/2017
Change 5-day change 1-year change 3-year change Capi.($)
-5.04%-33.93% - - 455M
+1.34%-3.97%+24.82%+9.21% 222B
+1.44%-2.53%+3.00%-20.96% 145B
+0.71%+0.39%-20.72%+19.80% 130B
+0.60%+0.42%-54.65%-9.79% 69.68B
+0.09%+0.04%+11.07%+18.91% 52.3B
+0.41%+0.51%-14.70%-13.84% 50.71B
+0.97%-2.38%+20.91%+24.18% 42.28B
+1.57%-0.48%+39.03%+46.68% 39.87B
-0.21%-2.05%-14.80%+45.03% 33.37B
Average +0.19%-1.55%-0.67%+13.25% 87.35B
Weighted average by Cap. +0.97%-2.12%+1.55%+7.08%

Financials

2026 *2027 *
Net sales 49M 42.27M 39.82M 36.28M 67.82M 4.63B 68.33M 471M 183M 2.37B 184M 180M 7.77B 56.55M 48.79M 45.96M 41.87M 78.27M 5.34B 78.85M 544M 211M 2.73B 212M 208M 8.97B
Net income -39.55M -34.12M -32.14M -29.28M -54.74M -3.74B -55.15M -381M -148M -1.91B -149M -145M -6.27B -38.75M -33.43M -31.49M -28.69M -53.63M -3.66B -54.03M -373M -145M -1.87B -146M -142M -6.15B
Net Debt - -
Logo MRI Interventions Inc
ClearPoint Neuro, Inc. is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The Company provides clinical products and preclinical development services for controlled drug and device delivery. Its business consists of two components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. The primary applications for the ClearPoint system are to target and guide the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, and the infusion of pharmaceuticals into the brain. It provides consulting services to its pharmaceutical and other medical technology partners.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-